Related Experiment Video
Updated: Jun 10, 2026
09:34
Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
Published on: February 9, 2019
Retinyl palmitate flexible polymeric nanocapsules: characterization and permeation studies
Zaine Teixeira1, Beatriz Zanchetta, Bruna A G Melo
1Instituto de Química, Universidade Estadual de Campinas, PO Box 6154, Campinas, SP, Brazil.
Colloids and Surfaces. B, Biointerfaces
|July 27, 2010
Summary
Elastic polymeric nanocapsules loaded with retinyl palmitate were developed for enhanced skin permeation. These nanocarriers demonstrate deformability and penetrate deep skin layers, suggesting a promising strategy for active ingredient delivery.
Area of Science:
- Materials Science
- Nanotechnology
- Dermatology
Background:
- Effective delivery of active ingredients like retinyl palmitate into deeper skin layers remains a challenge.
- Polymeric nanocarriers offer potential for controlled release and enhanced penetration.
- Understanding nanocarrier-skin interactions is crucial for optimizing topical formulations.
Purpose of the Study:
- To prepare and characterize elastic polymeric nanocapsules for enhanced skin permeation.
- To investigate the deformability and skin penetration capabilities of these nanocapsules.
- To elucidate the intercellular permeation mechanism of nanocapsules in human skin.
Main Methods:
- Pre-formed polymer interfacial deposition method for nanocapsule preparation.
- Dynamic Light Scattering (DLS) for size distribution analysis.
- Transmission Electron Microscopy (TEM) and Confocal Laser Scanning Microscopy (CLSM) for morphology and permeation studies.
- Franz diffusion cell for in vitro skin permeation assays.
Main Results:
- Polymeric nanocapsules with a narrow size distribution (215 nm, PDI 0.10) were successfully prepared.
- Nanoparticles exhibited deformability, enabling passage through small pores.
- Retinyl palmitate demonstrated permeation into deeper skin layers.
- CLSM analysis revealed uniform nanocapsule distribution, indicating an intercellular permeation pathway.
Conclusions:
- Elastic poly(D,L-lactide) nanocapsules effectively deliver retinyl palmitate into deep skin layers.
- The intercellular permeation mechanism suggests efficient transport across the stratum corneum.
- These nanocapsules represent a viable strategy for enhancing topical active ingredient delivery to deeper skin tissues.
More Related Videos
Related Concept Videos
01:27Bioavailability Enhancement: Drug Permeability Enhancement
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:22Modified-Release Drug Delivery Systems: Drug Release Characteristics
Drug release from modified-release dosage forms is designed to achieve specific therapeutic effects by controlling the rate and extent of drug release. The classification of these drug release systems is based on key pharmacokinetic assumptions: drug disposition follows first-order kinetics, drug release is the rate-limiting step in absorption, and the released drug is rapidly and completely absorbed.There are four major models of drug release patterns. The first model is the slow zero-order...
01:05Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:30Modified-Release Drug Delivery Systems: Bioavailability
Modified-release (MR) dosage forms are designed to extend drug release over time, thereby maintaining stable plasma concentrations and reducing dosing frequency. However, their bioavailability is typically below 100% due to incomplete drug release and presystemic metabolism, and limitations in drug permeability across the gastrointestinal epithelium, all of which can restrict the fraction of the drug reaching systemic circulation. Consequently, studying the in vivo bioavailability of MR...